BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 20101232)

  • 1. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
    Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
    Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERalpha suppresses slug expression directly by transcriptional repression.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Barsky SH
    Biochem J; 2008 Dec; 416(2):179-87. PubMed ID: 18588516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
    Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.
    Park SH; Cheung LW; Wong AS; Leung PC
    Mol Endocrinol; 2008 Sep; 22(9):2085-98. PubMed ID: 18550773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
    Belguise K; Guo S; Sonenshein GE
    Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
    Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
    Liu X; Feng R
    Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):496-501. PubMed ID: 20705589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
    Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation.
    Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer RJ
    Carcinogenesis; 2009 Oct; 30(10):1781-8. PubMed ID: 19654099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.
    Wang M; Zhao F; Li S; Chang AK; Jia Z; Chen Y; Xu F; Pan H; Wu H
    PLoS One; 2013; 8(6):e65556. PubMed ID: 23762395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.